Mega randomized clinical trials: a definitive solution or a double-edged sword?

Lemaitre, Florian; Laviolle, Bruno

Lemaitre, Florian; Laviolle, Bruno.

Lemaitre F; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), UMR_S 1085, 35000, Rennes, France. florian.lemaitre@chu-rennes.fr.
Laviolle B; INSERM, Centre d'Investigation Clinique, CIC 1414, F-35000, Rennes, France. florian.lemaitre@chu-rennes.fr.

Eur J Clin Pharmacol ; 78(2): 305-306, 2022 Feb.

Article in English | MEDLINE | ID: covidwho-1653433

Subject(s)

COVID-19 Drug Treatment; Randomized Controlled Trials as Topic/methods; Sample Size; Humans; Pandemics; Randomized Controlled Trials as Topic/standards; Research Design; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Sample Size / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Eur J Clin Pharmacol Year: 2022 Document Type: Article Affiliation country: S00228-021-03230-w

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google